ArticleFrontiers in medicine2025
Retinal vessel metric analysis of type 1 diabetes mellitus in OCT angiography.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate retinal vascular characteristics in type 1 diabetes mellitus (T1DM) patients at different stages via optical coherence tomography angiography (OCTA). Design: A retrospective observational study. Method: 63 T1DM patients (110 eyes) who underwent OCTA (3*3 mm) examination and 40 age-matched healthy individuals (79 eyes) were included. A deep learning model was used to segment the retinal arteries and veins on OCTA images, and the vascular metrics in the macular area, including fractal dimension (FD), vessel diameter index (VDI), vascular length fraction (VLF), vascular tortuosity, and vessel density (VD) in different zones (fovea, superior parafoveal, inferior parafoveal, nasal parafoveal, and temporal parafoveal) were calculated. Results: In accordance to the diagnostic criteria for diabetic retinopathy (DR), T1DM patients were classified into groups. There were 12 individuals (19 eyes) in the NPDR group, all of whom exhibited non-proliferative DR, and 51 (91 eyes) in the NDR (non-DR) group. The NDR group was divided into 2 subgroups according to the duration of T1DM, with 28 people (49 eyes) having a duration of less than 5 years and 23 people (42 eyes) having a duration of 5 years or more. Built-in metrics of OCTA showed that the VD in each zone of NPDR group was significantly lower than that of control group and NDR group (all Conclusion: We employed a deep learning vessel segmentation model to analyze the changes in arterial and venous metrics in OCTA images of T1DM patients. Early damage of NPDR to large vessels occurs in the inferior parafoveal vein and the superior parafoveal artery. In patients without DR, the arterial VD of the inferior parafovea has a compensatory increase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.